Compare ALEMBIC PHARMA with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PANACEA BIOTECH ALEMBIC PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 16.4 15.1 108.8% View Chart
P/BV x 6.5 5.9 111.0% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
PANACEA BIOTECH
Mar-19
ALEMBIC PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs664354 187.8%   
Low Rs412138 298.4%   
Sales per share (Unadj.) Rs208.774.6 279.9%  
Earnings per share (Unadj.) Rs31.06.7 464.1%  
Cash flow per share (Unadj.) Rs37.115.5 239.5%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.257.2 252.1%  
Shares outstanding (eoy) m188.5261.25 307.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.3 78.2%   
Avg P/E ratio x17.436.8 47.2%  
P/CF ratio (eoy) x14.515.9 91.4%  
Price / Book Value ratio x3.74.3 86.8%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46115,061 673.7%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m7,4671,471 507.7%   
Avg. sales/employee Rs ThNM1,973.6-  
Avg. wages/employee Rs ThNM635.6-  
Avg. net profit/employee Rs ThNM176.8-  
INCOME DATA
Net Sales Rs m39,3474,567 861.5%  
Other income Rs m9445 209.4%   
Total revenues Rs m39,4414,612 855.2%   
Gross profit Rs m8,7362,030 430.4%  
Depreciation Rs m1,152540 213.4%   
Interest Rs m1841,048 17.6%   
Profit before tax Rs m7,493486 1,541.2%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56877 2,033.1%   
Profit after tax Rs m5,844409 1,428.4%  
Gross profit margin %22.244.4 50.0%  
Effective tax rate %20.915.9 131.9%   
Net profit margin %14.99.0 165.8%  
BALANCE SHEET DATA
Current assets Rs m19,5772,415 810.8%   
Current liabilities Rs m14,8969,077 164.1%   
Net working cap to sales %11.9-145.9 -8.2%  
Current ratio x1.30.3 494.1%  
Inventory Days Days9065 137.9%  
Debtors Days Days4571 64.0%  
Net fixed assets Rs m27,0978,333 325.2%   
Share capital Rs m37761 615.0%   
"Free" reserves Rs m26,8113,443 778.8%   
Net worth Rs m27,1883,504 775.9%   
Long term debt Rs m4,993461 1,082.6%   
Total assets Rs m47,77813,755 347.3%  
Interest coverage x41.71.5 2,848.9%   
Debt to equity ratio x0.20.1 139.5%  
Sales to assets ratio x0.80.3 248.0%   
Return on assets %12.610.6 119.1%  
Return on equity %21.511.7 184.1%  
Return on capital %23.638.7 61.0%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m19,4531,203 1,617.0%   
Fx outflow Rs m6,065467 1,299.6%   
Net fx Rs m13,388736 1,818.1%   
CASH FLOW
From Operations Rs m8,1201,049 774.2%  
From Investments Rs m-7,556-54 14,123.4%  
From Financial Activity Rs m590-1,011 -58.4%  
Net Cashflow Rs m1,153-20 -5,854.3%  

Share Holding

Indian Promoters % 74.1 74.5 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.6 483.3%  
FIIs % 9.1 1.3 700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 23.6 58.9%  
Shareholders   49,328 10,259 480.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   VENUS REMEDIES  NEULAND LABS  PIRAMAL ENTERPRISES  J.B.CHEMICALS  ALKEM LABORATORIES  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 6, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - UNICHEM LAB COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS